Oral Solid Dosage Contract Manufacturing Market Forecast 2025-2034: Analysing Major Trends, Opportunities, and Growth Drivers

"How Will the Oral Solid Dosage Contract Manufacturing Market Grow, and What Is the Projected Market Size?
In recent years, the market size for contract manufacturing of oral solid dosage has seen robust growth. Projections indicate its rise from $39.39 billion in 2024 to $42.51 billion in 2025, establishing a compound annual growth rate (CAGR) of 7.9%. Factors such as the increasing global population, chronic disease prevalence, and an enhanced emphasis on research and development were instrumental in this growth during the historical period.

The market size for contract manufacturing of oral solid dosage is predicted to experience robust expansion in the coming years. The projected growth indicates that by 2029 it will be worth $56.89 billion, growing at a compounded annual growth rate (CAGR) of 7.6%. This predicted rise during the forecast period is primarily due to the upsurge in outsourcing from pharmaceutical firms, the progress made in drug delivery technology, and the escalating activities surrounding drug development. Key trends expected in the forecast duration encompass progression in drug delivery technology, the introduction of 3D printing, and the evolution of controlled-release technologies.

What Is Stimulating Growth in the Oral Solid Dosage Contract Manufacturing Market?
The oral solid dosage contract manufacturing market is likely to experience growth largely from the rising demand for generic drugs. These medications, which match brand-name drugs in dosage, strength, safety, quality, and intended use, are becoming increasingly popular due to patent expirations, cost control measures, regulatory incentives, and greater accessibility to healthcare. Oral solid dosage contract manufacturing plays a crucial role in producing and distributing generic drugs, making optimal use of contract manufacturers' abilities to bolster operational efficiency, cut costs, maintain high production quality, and expedite their products' market entry. For example, data from the US Food and Drug Administration, a federal agency, showed that generic drugs made up approximately 91% of all prescriptions in the USA in 2022, with the FDA approving more than 32,000 generic drugs. Consequently, the demand for generic drugs is spurring the expansion of the oral solid dosage contract manufacturing market.

Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=16137&type=smp

Who Are the Major Industry Players Fueling Oral Solid Dosage Contract Manufacturing Market Expansion?
Major companies operating in the oral solid dosage contract manufacturing market are Pfizer Inc., Takeda Pharmaceutical Company Limited, Gilead Sciences Inc., Amgen Inc., Merck KGaA, Siemens Healthineers AG, Evonik Industries AG, Teva Pharmaceutical Industries Ltd., Lonza Group AG, Catalent Inc., Patheon Pharma Services, Fareva Holding SA, Piramal Enterprises Limited, Hetero Drugs Limited, Siegfried Holding AG, Recipharm AB, Almac Group Limited, Aenova Holding GmbH, Jubilant Pharmova Limited, Cambrex Corporation, International Chemical Investors Group (ICIG) operates under the CordenPharma brand, Ajinomoto Co. Inc., Hovione Holding Ltd., Alcami Corporation

Which Key Developments Are Influencing the Oral Solid Dosage Contract Manufacturing Market?
Leading companies in the oral solid dosage contract manufacturing market are concentrating on developing inventive solutions such as continuous manufacturing lines to maintain their market stand. Continuous manufacturing lines are manufacturing systems or facilities that use unbroken manufacturing methods to create pharmaceuticals or similar goods. For instance, WuXi STA, a pharmaceutical firm based in China, unveiled its initial continuous manufacturing line for oral solid pharmaceutical products in January 2023. This advanced facility symbolizes a substantial improvement in medicine production, applying continuous manufacturing concepts to boost efficiency, quality, and adaptability in drug manufacturing procedures. This nimbleness condenses production schedules and minimizes downtime, ultimately hastening the distribution of essential drugs to individuals.

How Is the Segmentation of the Oral Solid Dosage Contract Manufacturing Market Defined?
The oral solid dosage contract manufacturing market covered in this report is segmented -

1) By Product Type: Tablets, Capsules, Powders, Granules, Other Product Types
2) By Service: Drug Product Development, Fill Finish Product Manufacturing, API Manufacturing, Packaging And Labelling, Other Applications
3) By Therapeutic Area: Oncology, Cardiovascular Diseases, Metabolic Disorders, Neurological Disorders, infectious Diseases, Gastrointestinal Diseases, Other Therapeutic Areas
4) By End User: Large Size Companies, Medium And Small Size Companies

Subsegments:
1) By Tablets: Compressed Tablets, Effervescent Tablets, Chewable Tablets, Coated Tablets (Enteric, Film Coated), Sustained Or Controlled Release Tablets
2) By Capsules: Hard Gelatin Capsules, Soft Gel Capsules, Vegetarian Capsules, Liquid-Filled Capsules, Delayed Release Capsules
3) By Powders: Powders For Oral Suspension, Powders For Direct Compression, Powders For Mixing Or Blending, Instant Dissolving Powders
4) By Granules: Granules For Direct Compression, Granules For Tabletting, Effervescent Granules, Delayed Or Controlled Release Granules
5) By Other Product Types: Lozenges, Oral Strips, Oral Thin Films, Effervescent Tablets Or Granules

Pre-Book Your Report Now For A Swift Delivery:
https://www.thebusinessresearchcompany.com/report/oral-solid-dosage-contract-manufacturing-global-market-report

What Is the Leading Region in the Oral Solid Dosage Contract Manufacturing Market?
Asia-Pacific was the largest region in the oral solid dosage contract manufacturing market in 2023. The regions covered in the oral solid dosage contract manufacturing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

What Is Covered In The Oral Solid Dosage Contract Manufacturing Global Market Report?

- Market Size Analysis: Analyze the Oral Solid Dosage Contract Manufacturing Market size by key regions, countries, product types, and applications.
- Market Segmentation Analysis: Identify various subsegments within the Oral Solid Dosage Contract Manufacturing Market for effective categorization.
- Key Player Focus: Focus on key players to define their market value, share, and competitive landscape.
- Growth Trends Analysis: Examine individual growth trends and prospects in the Market.
- Market Contribution: Evaluate contributions of different segments to the overall Oral Solid Dosage Contract Manufacturing Market growth.
- Growth Drivers: Detail key factors influencing market growth, including opportunities and drivers.
- Industry Challenges: Analyze challenges and risks affecting the Oral Solid Dosage Contract Manufacturing Market.
- Competitive Developments: Analyze competitive developments, such as expansions, agreements, and new product launches in the market.

Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=16137

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.
Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.